These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1865422)
1. Bone remodelling after growth factor and cyclosporine A therapy for aplastic anemia. Derfus BA; Csuka ME; Carrera GF; Hanson GA; Smith RE J Rheumatol; 1991 May; 18(5):738-42. PubMed ID: 1865422 [TBL] [Abstract][Full Text] [Related]
2. Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor. Escobar-Morreale HF; Bravo P; García-Robles R; García-Laraña J; de la Calle H; Sancho JM Thyroid; 1997 Feb; 7(1):67-70. PubMed ID: 9086574 [TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis. Champlin RE; Nimer SD; Oette D; Golde DW Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137 [No Abstract] [Full Text] [Related]
4. Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor. Otsubo H; Kaito K; Sekita T; Shimada T; Kobayashi M; Hosoya T Int J Hematol; 1998 Dec; 68(4):445-8. PubMed ID: 9885444 [TBL] [Abstract][Full Text] [Related]
5. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. Frickhofen N; Kaltwasser JP; Schrezenmeier H; Raghavachar A; Vogt HG; Herrmann F; Freund M; Meusers P; Salama A; Heimpel H N Engl J Med; 1991 May; 324(19):1297-304. PubMed ID: 2017225 [TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive therapy for aplastic anemia--review]. Xu CY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):348-52. PubMed ID: 15854308 [TBL] [Abstract][Full Text] [Related]
7. [Progress in biology and therapy of aplastic anemia and other conditions of bone marrow failure]. Robak T Postepy Hig Med Dosw; 1992; 46(1):21-51. PubMed ID: 1641375 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow changes in patients with refractory aplastic anemia treated by recombinant GM-CSF. Naeim F; Champlin R; Nimer S Hematol Pathol; 1990; 4(2):79-85. PubMed ID: 2197266 [TBL] [Abstract][Full Text] [Related]
9. Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine. Hama A; Takahashi Y; Muramatsu H; Ito M; Narita A; Kosaka Y; Tsuchida M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S Haematologica; 2015 Nov; 100(11):1426-33. PubMed ID: 26273061 [TBL] [Abstract][Full Text] [Related]
10. Eosinophilic fasciitis and severe aplastic anemia: favorable response to either antithymocyte globulin or cyclosporine A in blood and skin disorders. Debusscher L; Bitar N; De Maubeuge J; De Conninck G; Stryckmans P Transplant Proc; 1988 Jun; 20(3 Suppl 4):310-3. PubMed ID: 3381290 [No Abstract] [Full Text] [Related]
11. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. Vadhan-Raj S; Buescher S; Broxmeyer HE; LeMaistre A; Lepe-Zuniga JL; Ventura G; Jeha S; Horwitz LJ; Trujillo JM; Gillis S N Engl J Med; 1988 Dec; 319(25):1628-34. PubMed ID: 3059191 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporine and recombinant granulocyte colony-stimulating factor in severe aplastic anemia. Kojima S; Fukuda M; Miyajima Y; Matsuyama T N Engl J Med; 1990 Sep; 323(13):920-1. PubMed ID: 1697647 [No Abstract] [Full Text] [Related]
13. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults. Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461 [TBL] [Abstract][Full Text] [Related]
14. New approach of treatment of severe aplastic anemia. Cooperative Group on the Treatment of Aplastic Anemia. Gluckman E; Bourdeau-Esperou H; Boogaerts M; Briere J; Navarro J; Leverger G; Leporrier M; Reiffers J; Janvier M; Michallet M Bone Marrow Transplant; 1991; 7 Suppl 2():106-7. PubMed ID: 1878666 [No Abstract] [Full Text] [Related]
15. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors. Aoki A; Shibata A Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342 [TBL] [Abstract][Full Text] [Related]
16. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials. Nissen-Druey C Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852 [No Abstract] [Full Text] [Related]
17. Therapy of aplastic anemia with sequential antithymocyte globulin and cyclosporin. Doolittle GC; Bodensteiner DC; Skikne BS; Amare M Am J Hematol; 1991 Feb; 36(2):144-6. PubMed ID: 2012065 [TBL] [Abstract][Full Text] [Related]
18. [Current status of the drug therapy of sever aplastic anemia]. Zhang MH Zhonghua Nei Ke Za Zhi; 1991 May; 30(5):302-4. PubMed ID: 1879244 [No Abstract] [Full Text] [Related]
19. Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions. Ljungman P; Lawler M; Lönnqvist B; Ringdén O; Shanwell A Bone Marrow Transplant; 1996 Dec; 18(6):1179-81. PubMed ID: 8971392 [TBL] [Abstract][Full Text] [Related]
20. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia. Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]